Cost-Effectiveness Analysis of a Rehabilitation Protocol With FES Cycling in Persons With Complete SCI
NCT ID: NCT04592679
Last Updated: 2020-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2015-01-01
2020-07-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary outcome was the thigh circumferences measured at 4 different levels (5-10-15-20 cm) from the superior margin of the patella, while the secondary outcomes were the muscle tone evaluated with Modified Ashworth Scale (MAS) and the sensation of pain registered with International Spinal Cord Injury - Pain Basic Data Set (ISCI-P).
From these outcomes the Quality Adjusted Life Years (QALYs) was obtained. The costs of the two treatments were calculated through a consultation process with the Competent Offices of the two hospitals. The QALYs and the costs were used to calculate the Incremental Cost-Effectiveness Ratio (ICER) in order to verify the cost-effectiveness ratio of the two treatments.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Muscle and Bone Changes After 6 Months of FES Cycling
NCT06321172
Early FES Cycling in Acute Spinal Cord Injury for Neuromuscular Preservation and Neurorecovery
NCT05255679
Functional Electrical Stimulation During Cycling in People With Spinal Cord Injury
NCT03834324
Investigation Into Optimal FES Training Characteristics After Spinal Cord Injury
NCT03621254
FES Rowing for Skeletal Health After SCI
NCT02008149
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FES-C
FES-C
The participants were submitted to 20 sessions of FES-C three/five times per week. Each session lasted about 30'.
Standard
Standard Treatment
The participants were submitted to 20 sessions of standard rehabilitation for lower limbs with manual mobilization, three/five times per week. Each session lasted about 30'.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FES-C
The participants were submitted to 20 sessions of FES-C three/five times per week. Each session lasted about 30'.
Standard Treatment
The participants were submitted to 20 sessions of standard rehabilitation for lower limbs with manual mobilization, three/five times per week. Each session lasted about 30'.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* loss of gait function
* any episode of autonomic dysreflexia
* any important range of motion limitation to hips, knees or ankles
* eccitability of the muscles
* FES tollerability
Exclusion Criteria
* psychiatric diseases
* cancer
* recent fractures
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Ospedaliero, Universitaria Pisana
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matteo Olivieri
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3879B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.